12 Feb 2026
10:30 CET |
HEXAOM |
AGENDA FINANCIER 2026
|
40202010 Home Construction |
Legal |
12 Feb 2026
08:45 CET |
VICAT |
The Vicat Group awarded a “Grand Projets Industriels de Décarbonation” (GPID) grant for its VAIA project
|
50101030 Cement |
Corporate life |
12 Feb 2026
08:45 CET |
VICAT |
Le groupe Vicat est lauréat d’une subvention Grands Projets Industriels de Décarbonation (GPID) pour son projet VAIA
|
50101030 Cement |
Corporate life |
12 Feb 2026
08:31 CET |
UMALIS GROUP |
Launch of a 95% AI-Automated Umbrella Employment Subsidiary
|
50205020 Professional Business Support Services |
New establishment |
12 Feb 2026
08:29 CET |
UMALIS GROUP |
Lancement d'une filiale de portage salarial automatisée à 95 % par intelligence artificielle
|
50205020 Professional Business Support Services |
New establishment |
12 Feb 2026
08:01 CET |
MYHOTELMATCH |
MyHotelMatch: Informations complémentaires à ses actionnaires et aux marchés
|
40501015 Travel and Tourism |
Other subject |
12 Feb 2026
08:01 CET |
MYHOTELMATCH |
MyHotelMatch: Additional information for its shareholders and the markets
|
40501015 Travel and Tourism |
Other subject |
12 Feb 2026
08:00 CET |
HERMES INTERNATIONAL |
Hermès International: 2025 Full-Year Results
|
40204020 Clothing and Accessories |
Income |
12 Feb 2026
08:00 CET |
HERMES INTERNATIONAL |
Hermès International : Résultats annuels 2025
|
40204020 Clothing and Accessories |
Income |
12 Feb 2026
08:00 CET |
TRACTIAL |
Recentrage stratégique : TRACTIAL ajuste son périmètre pour renforcer sa trajectoire fintech
|
10101020 Consumer Digital Services |
Other subject |
12 Feb 2026
07:55 CET |
VIRTUALWARE |
Virtualware Issues 2026 Guidance: Expects Organic Revenue Growth Exceeding 30% and EBITDA Margins of 20-25%
|
10101010 Computer Services |
- |
12 Feb 2026
07:55 CET |
VIRTUALWARE |
Virtualware publica su guidance para 2026: prevé un crecimiento orgánico superior al 30% y un EBITDA del 20-25%
|
10101010 Computer Services |
- |
12 Feb 2026
07:45 CET |
ICAPE HOLDING |
ICAPE: Consolidated Annual Revenue 2025
|
10102010 Semiconductors |
Sales |
12 Feb 2026
07:45 CET |
ICAPE HOLDING |
ICAPE : Chiffre d’affaires consolidé annuel 2025
|
10102010 Semiconductors |
Sales |
12 Feb 2026
07:30 CET |
VIRIDIEN |
Publication of the 2025 annual financial results on Thursday, February 26, after market close
|
60101030 Oil Equipment and Services |
Meetings / events |
12 Feb 2026
07:30 CET |
VIRIDIEN |
Publication des résultats financiers de l’année 2025, le jeudi 26 février 2026 après bourse
|
60101030 Oil Equipment and Services |
Meetings / events |
12 Feb 2026
07:30 CET |
NICOX S.A. |
Nicox confirme son éligibilité au PEA-PME
|
20103015 Pharmaceuticals |
Legal |
12 Feb 2026
07:30 CET |
SANOFI |
Press Release: Belén Garijo to become Chief Executive Officer of Sanofi
|
20103015 Pharmaceuticals |
Other subject |
12 Feb 2026
07:30 CET |
SANOFI |
Communiqué de presse : Belén Garijo nommée Directrice générale de Sanofi
|
20103015 Pharmaceuticals |
Other subject |
12 Feb 2026
07:30 CET |
UNIBAIL-RODAMCO-WESTFIELD |
UNIBAIL-RODAMCO-WESTFIELD REPORTS FY-2025 EARNINGS
|
35102045 Retail REITs |
Income |
12 Feb 2026
07:30 CET |
CARREFOUR |
Press release - Carrefour announces the sale of Carrefour Romania
|
45201010 Food Retailers and Wholesalers |
Mergers, Acquisitions, Transfers |
12 Feb 2026
07:30 CET |
CARREFOUR |
Communiqué de presse - Carrefour annonce la cession de Carrefour Roumanie
|
45201010 Food Retailers and Wholesalers |
Mergers, Acquisitions, Transfers |
12 Feb 2026
07:30 CET |
FORSEE POWER |
Transfert effectif des titres FORSEE POWER sur Euronext Growth® Paris et radiation de leur cotation sur le marché réglementé d’Euronext Paris
|
50202010 Electrical Components |
Other subject |
12 Feb 2026
07:30 CET |
FORSEE POWER |
Effective Transfer of FORSEE POWER Shares to Euronext Growth® Paris and Delisting From the Euronext Paris Regulated Market
|
50202010 Electrical Components |
Other subject |
12 Feb 2026
07:30 CET |
LEGRAND |
Legrand: 2025 Full-Year Results
|
50202010 Electrical Components |
Other subject |
12 Feb 2026
07:30 CET |
LEGRAND |
Legrand : Publication annuelle 2025
|
50202010 Electrical Components |
Other subject |
12 Feb 2026
07:30 CET |
LEGRAND |
Legrand : Modalités de mise à disposition des comptes consolidés au 31 décembre 2025
|
50202010 Electrical Components |
Other subject |
12 Feb 2026
07:30 CET |
LEGRAND |
Release of Legrand’s Consolidated Financial Statements as of December 31, 2025
|
50202010 Electrical Components |
Other subject |
12 Feb 2026
07:00 CET |
TERACT S.A. |
TERACT - Chiffre d’affaires du 1er semestre 2025-2026
|
40401010 Diversified Retailers |
General meeting / Board Meeting |
12 Feb 2026
07:00 CET |
TERACT S.A. |
TERACT - H1 2025-2026 Revenue
|
40401010 Diversified Retailers |
General meeting / Board Meeting |
12 Feb 2026
07:00 CET |
IPSEN |
Ipsen delivers strong results in 2025, driven by solid execution across all therapeutic areas, and provides 2026 guidance
|
20103015 Pharmaceuticals |
Commercial results |
12 Feb 2026
07:00 CET |
IPSEN |
Ipsen réalise de solides résultats en 2025, grâce à une performance soutenue de toutes les aires thérapeutiques, et annonce ses objectifs 2026
|
20103015 Pharmaceuticals |
Commercial results |
11 Feb 2026
20:17 CET |
TOTALENERGIES EP GABON |
TOTALENERGIES EP GABON : CHIFFRE D’AFFAIRES 2025
|
60101010 Oil: Crude Producers |
Income |
11 Feb 2026
20:17 CET |
TOTALENERGIES EP GABON |
TotalEnergies EP Gabon: 2025 Revenues
|
60101010 Oil: Crude Producers |
Income |
11 Feb 2026
20:03 CET |
ANDINO INVERSIONES GLOBAL, S.A |
AIG - CALL TO THE EXTRAORDINARY SHAREHOLDERS GENERAL MEETING - MARCH 2026
|
50206060 Transportation Services |
General meeting / Board Meeting |
11 Feb 2026
19:47 CET |
LECTRA |
LECTRA: Q4 and Full Year 2025 financial report available
|
10101015 Software |
Income |
11 Feb 2026
19:47 CET |
LECTRA |
LECTRA : Mise à disposition du rapport sur l'activité et les comptes consolidés du quatrième trimestre et de l’exercice 2025
|
10101015 Software |
Income |
11 Feb 2026
19:42 CET |
LECTRA |
LECTRA: 2025 results: growth in recurring revenues and operational resilience
|
10101015 Software |
Income |
11 Feb 2026
19:42 CET |
LECTRA |
LECTRA : Résultats 2025 : croissance du récurrent et résilience opérationnelle
|
10101015 Software |
Income |
11 Feb 2026
19:38 CET |
TOTALENERGIES EP GABON |
TotalEnergies EP Gabon : Nombre total d’actions et de droits de vote au 31 janvier 2026
|
60101010 Oil: Crude Producers |
Other subject |
11 Feb 2026
18:37 CET |
REXEL |
Rexel : Erratum to the Press release Q4 sales & FY 2025 results
|
50202010 Electrical Components |
Income |
11 Feb 2026
18:37 CET |
REXEL |
Rexel : Rectificatif au Communiqué de Presse Ventes du T4 & résultats 2025
|
50202010 Electrical Components |
Income |
11 Feb 2026
18:30 CET |
SANOFI |
Sanofi: Information concerning the total number of voting rights and shares – January 2026
|
20103015 Pharmaceuticals |
Share history |
11 Feb 2026
18:30 CET |
SANOFI |
Sanofi: Informations relatives au nombre de droits de vote et d'actions – JANVIER 2026
|
20103015 Pharmaceuticals |
Share history |
11 Feb 2026
18:14 CET |
ESSILORLUXOTTICA |
EssilorLuxottica: EssilorLuxottica Board of Directors Proposes Renewal of Eight Directors
|
20102015 Medical Supplies |
Other subject |
11 Feb 2026
18:14 CET |
ESSILORLUXOTTICA |
EssilorLuxottica: Le Conseil d’administration d’EssilorLuxottica propose la nomination de huit administrateurs et administratrices
|
20102015 Medical Supplies |
Other subject |
11 Feb 2026
18:14 CET |
ESSILORLUXOTTICA |
EssilorLuxottica: Il Consiglio di Amministrazione di EssilorLuxottica propone il rinnovo di otto Amministratori
|
20102015 Medical Supplies |
Other subject |
11 Feb 2026
18:08 CET |
HOPSCOTCH GROUPE |
HOPSCOTCH GROUPE : Droits de vote et actions - Janvier 2026
|
40301020 Media Agencies |
Share history |
11 Feb 2026
18:04 CET |
ESSILORLUXOTTICA |
EssilorLuxottica: Q4/FY 2025 Results - Revenue growing 18.4% in Q4 and 11.2% in the FY. Adj. operating margin at 16.0% in the FY
|
20102015 Medical Supplies |
Commercial results |
11 Feb 2026
18:04 CET |
ESSILORLUXOTTICA |
EssilorLuxottica: Résultats T4 et annuels 2025 - Hausse de +18,4 % du chiffre d'affaires au T4 et de +11,2 % sur l'exercice. Marge opérationnelle ajustée à 16,0 % sur l'exercice
|
20102015 Medical Supplies |
Commercial results |